Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2012 | 06-2012 | 05-2012 | 03-2012 | 02-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4 | N/A | 4 | N/A | 4 |
| TOTAL | $4 | $N/A | $4 | $N/A | $4 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4 | $N/A | $4 | $N/A | $4 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 0 | 10 | 0 | 10 |
| Accrued Expenses | 33 | N/A | 32 | N/A | 32 |
| TOTAL | $68 | $N/A | $68 | $N/A | $67 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $68 | $N/A | $68 | $N/A | $67 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107 | N/A | 107 | N/A | N/A |
| Retained earnings | -143 | N/A | -140 | N/A | -136 |
| TOTAL | $-64 | $N/A | $-64 | $N/A | $-63 |
| Total Liabilities And Equity | $4 | $0 | $4 | $0 | $4 |